Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock ...

As previously reported, Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral with a price target of $71, up from $62, citing ...

CVS Health CVS turned in solid fourth-quarter results, and its 2025 guidance for 6%-11% adjusted EPS growth without any share ...

Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral.Maximize Your Portfolio with Data Driven Insights:Leverage the power of ...

CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

Shares of CVS Health (NYSE: CVS) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results topped estimates and management offered better-than-expected guidance for 2025.

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...